Username Password
S&P 500: 2,061.02
Change: +0.24%

EXELIXIS INC. (EXEL)

Overview
Price 2.54
Price Change Today +$0.05 (+2.01%)
P&P rating Rating: 3
Open Price $2.49
Previous Close $2.49
Daily Range $2.47 - $2.55
52-Week Range $1.26 - $4.55
Volume 1
chart
Top Buy Analysis
BUY: EXEL Rating: 3
Company: EXELIXIS INC.
Points: -108.73
Start Price: $5.57
Start Date: 06/11/2008 6:52 PM
GreedsGood
GreedsGood
P&P Score: 66.08
Recs:
Undervalued

Comments: 0 | Comment

Top Sell Analysis
SELL: EXEL Rating: 3
Company: EXELIXIS INC.
Points: 134.93
Start Price: $9.35
Start Date: 06/19/2011 9:24 AM
Hqdepot
Hqdepot
P&P Score: 45.55
Recs:
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

28 Buy
1 Sell
 
Blog Posts
User User Score Date Title Comments Last Comment
zantriocom
0.00 03/10/10 Zantrio.com Free Daily Stock Picks 3-10-2010 0
zantriocom
0.00 11/09/09 Zantrio.com Free Daily Stock Picks 11-9-09 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 01/18/13 Pipeline Advances at Exelixis - Analyst Blog 0
Zacks_Analysts
0.00 12/20/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Zacks_Analysts
0.00 07/26/10 Sanofi Launches Cancer Treatment - Analyst Blog 0
Zacks_Analysts
0.00 06/30/10 Sanofi to Acquire TargaGen - Analyst Blog 0
Zacks_Analysts
0.00 06/22/10 BMY Terminates EXEL Partnership - Analyst Blog 0
Zacks_Analysts
0.00 06/18/10 FDA Approves Sanofi Drug - Analyst Blog 0
Zacks_Analysts
0.00 06/07/10 Sanofi Expands Oncology Pipeline - Analyst Blog 0
Pages: [ 1 ]  2  >>
Commentary
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.77
Points: -71.62
Created: 05/23/2013
Phase 3 trials nearing completion. Great preliminary results against various cancers.

Comments: 0 | Comment

Recs:
 
SELL: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $9.35
Points: +134.93
Created: 06/19/2011
I bought at 2.99 and took a 100+ gain at 6.45. Then I watched it ratchet up to 12. Makes you want to put on a blindfold and slide quarters into a slot machine. Anyway. It looks tenuous here and the news concerning side effects of their big Phase 3 drug is not promising. I see some downside to the 6.5 area here.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $12.35
Points: -132.41
Created: 04/26/2011
Ready to break out of weekly and monthly charts plus close to breaking out of short term consolidation

Comments: 1 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.21
Points: -130.77
Created: 12/14/2010
promising medicin

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -108.73
Created: 06/11/2008
Undervalued

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $6.50
Points: -110.58
Created: 06/04/2008
Phase 2 and 3's are coming!!!! 500% gain in 5 years if not more.

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $5.57
Points: -124.75
Created: 10/19/2011
buy

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $4.33
Points: -117.53
Created: 10/12/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $3.58
Points: -129.53
Created: 07/06/2010

Comments: 0 | Comment

Recs:
 
BUY: EXELIXIS INC. (EXEL) Rating: 3
Start Price: $7.20
Points: -105.12
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
BriansLongshots 54.19 BUY Three Plus Years 05/23/2013 $4.77 $2.54
(+2.01%)
-46.75% +24.87% -71.62 view
rtezanos 99.76 BUY Week or Less 10/19/2011 $5.57 $2.54
(+2.01%)
-54.40% +70.35% -124.75 view
Hqdepot 45.55 SELL Six Months to a Year 06/19/2011 $9.35 $2.54
(+2.01%)
-72.83% +62.09% +134.93 view
wallstreeter 45.58 BUY Six Months to a Year 04/26/2011 $12.35 $2.54
(+2.01%)
-79.43% +52.98% -132.41 view
cmmtgnmn 44.85 BUY Six Months to a Year 12/14/2010 $7.21 $2.54
(+2.01%)
-64.77% +66.00% -130.77 view
EyePhone 66.23 BUY One to Three Months 10/12/2010 $4.33 $2.54
(+2.01%)
-41.34% +76.19% -117.53
HardTimes 64.87 BUY One to Three Months 07/06/2010 $3.58 $2.54
(+2.01%)
-29.05% +100.48% -129.53
GreedsGood 66.08 BUY One to Three Years 06/11/2008 $5.57 $2.54
(+2.01%)
-54.40% +54.33% -108.73 view
POTASHKing 11.49 BUY Three Plus Years 06/04/2008 $6.50 $2.54
(+2.01%)
-60.92% +49.65% -110.58 view
Dave Brushart 71.75 BUY Six Months to a Year 01/01/2008 $7.20 $2.54
(+2.01%)
-64.72% +40.40% -105.12
Pages: [ 1 ]  2   3  >>
Sponsored Links